• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    C4 Therapeutics, Inc. - Common Stock (NQ: CCCC )

    6.320 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 11
    Open 6.320
    Bid (Size) 6.310 (1)
    Ask (Size) 6.420 (2)
    Prev. Close 6.320
    Today's Range 6.320 - 6.320
    52wk Range 1.060 - 11.88
    Shares Outstanding 48,797,226
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From C4 Therapeutics, Inc.
    Via GlobeNewswire
    C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
    From C4 Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -3.07%
    -3.07%
    1 Month
    -21.98%
    -21.98%
    3 Month
    -0.16%
    -0.16%
    6 Month
    +318.54%
    +318.54%
    1 Year
    +95.06%
    +95.06%

    More News

    Read More
    C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
    From C4 Therapeutics, Inc.
    Via GlobeNewswire
    Breaking Down C4 Therapeutics: 4 Analysts Share Their Views
    Via Benzinga
    Analyst Expectations For C4 Therapeutics's Future
    Via Benzinga
    C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024
    From C4 Therapeutics, Inc.
    Via GlobeNewswire
    C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
    From C4 Therapeutics, Inc.
    Via GlobeNewswire
    C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
    From C4 Therapeutics, Inc.
    Via GlobeNewswire
    C4 Therapeutics Inc. (NASDAQ: CCCC) Leading the Way in Wednesday Trading Based on Percentage Gain
    Via Investor Brand Network
    Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    7 Exciting Stocks Poised for Explosive Growth in Key Sectors
    Via InvestorPlace
    C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
    From C4 Therapeutics, Inc.
    Via GlobeNewswire
    C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
    From C4 Therapeutics, Inc.
    Via GlobeNewswire
    C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From C4 Therapeutics, Inc.
    Via GlobeNewswire
    MarketBeat Week in Review – 12/18 - 12/22
    Via MarketBeat
    Topics Economy
    Exposures Interest Rates
    C4 Therapeutics blasts off: what's next?
    Via MarketBeat
    Topics ETFs
    C4 Therapeutics Inc. (NASDAQ: CCCC) Near Top of Volume Charts in Friday Trading
    Via Investor Brand Network
    What's Going On With C4 Therapeutics Stock?
    Via Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    C4 Therapeutics Inc. (NASDAQ: CCCC) is One of Thursday Morning’s Most Active Stocks
    Via Investor Brand Network
    Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.